ANGLE plc (LON:AGL – Get Free Report)’s share price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 13.39 ($0.17) and traded as low as GBX 7.81 ($0.10). ANGLE shares last traded at GBX 8.25 ($0.11), with a volume of 834,348 shares.
Wall Street Analysts Forecast Growth
Separately, Berenberg Bank reissued a “buy” rating and issued a GBX 70 ($0.91) price objective on shares of ANGLE in a report on Thursday, September 26th.
Get Our Latest Research Report on AGL
ANGLE Trading Up 3.1 %
About ANGLE
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.
See Also
- Five stocks we like better than ANGLE
- 3 Healthcare Dividend Stocks to Buy
- California Resources Stock Could Be a Huge Long-Term Winner
- How to invest in marijuana stocks in 7 steps
- Observability Wars: Datadog and Dynatrace Vie for Data Dominance
- How to Most Effectively Use the MarketBeat Earnings Screener
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.